Results 241 to 250 of about 3,303,380 (365)

Forum on Gandy's The Panoptic Sort| Forum on Gandy's The Panoptic Sort — Introduction

International Journal of Communication, 2022
Larry P. Gross
doaj   +2 more sources

When the Tube Won't Go: Strategies for Difficult Nasogastric Intubation. [PDF]

Cureus
Vakil H, Lagzouli A, Lowe E.
europepmc   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Can high private cough syrup sales act as a proxy for missed TB notifications in TB surveillance? [PDF]

Public Health Action
Gupta K, Shewade HD, Manickam P, Soni P, Baig VN, Dagar R, Parmar M, Saxena Y, Charan S, Abdullah H, Bhardwaj AK.   +10 more
europepmc   +1 more source

Integrating grey relation sorting and cost-benefit analysis for optimal asphalt pavement maintenance prioritisation [PDF]

Yan Zhang, Hao-Chang Li, Yuxin Zhang, Wenke Zang, Kaiwen Yao   +4 more
openalex   +1 more source

The Big Sort: College Reputation and Labor Market Outcomes

, 2015
W. Macleod, Evan Riehl, J. Saavedra, M. Urquiola   +3 more
semanticscholar   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source

P-POSSUM Falls Short: Predicting Morbidity in Ovarian Cancer (OC) Cytoreductive Surgery. [PDF]

Cancers (Basel)
Sideris M, Brincat MR, Blyuss O, Oxley SG, Sia J, Kalra A, Wei X, Fierheller CT, Ganesan S, Miller RE, El-Khouly F, Gooneratne M, Abbott T, Pang CL, Verma P, Shah S, Lawrence A, Jeyarajah A, Brockbank E, Phadnis S, Dilley J, Manchanda R.   +21 more
europepmc   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

Molecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker, Keren Zohar, Martin Böttcher, Thomas Wartmann, Henry Freudenstein, Maximilian Doelling, Mihailo Andric, Wenjie Shi, Or Kakhlon, Katrin Hippe, Beatrix Jahnke, Dimitrios Mougiakakos, Franziska Baenke, Daniel Stange, Roland S. Croner, Michal Linial, Ulf D. Kahlert   +16 more
wiley   +1 more source

Ultrasound spatiotemporally enables prolonged therapeutic mRNA translation in engineered bacteria for enhanced cancer immunotherapy. [PDF]

Theranostics
Liu Z, Wang L, An J, Zhou T, Wei M, Yang G, Wu P, Yuan L.   +7 more
europepmc   +1 more source